MAX-10181
- Generic Name
- MAX-10181
MAX-10181 in Patients With Advanced Solid Tumor
- First Posted Date
- 2022-01-19
- Last Posted Date
- 2022-01-19
- Lead Sponsor
- Maxinovel Pty., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT05196360
- Locations
- 🇨🇳
The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China
MAX-10181 Given Orally to Patients With Advanced Solid Tumor
- First Posted Date
- 2019-10-10
- Last Posted Date
- 2022-01-19
- Lead Sponsor
- Maxinovel Pty., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT04122339
- Locations
- 🇦🇺
Linear Clinical Research, Nedlands, Western Australia, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath